AI assistant
Cryoport, Inc. — Director's Dealing 2025
Mar 12, 2025
32876_dirs_2025-03-11_1fdd024b-b23d-4adc-867e-d3d92ebb5b3e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2025-03-09
Reporting Person: SHELTON JERRELL (Director, President, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-09 | Common Stock | M | 8250 | — | Acquired | 744192 | Direct |
| 2025-03-10 | Common Stock | S | 4173 | $4.8791 | Disposed | 740019 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-09 | Restricted Stock Rights | $ | M | 8250 | Disposed | Common Stock (8250) | Direct |
Footnotes
F1: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
F2: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
F3: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025.